BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Scientific Papers found: Click to Expand⟱
*BioAv∅, *ROS∅,
*Dose∅, *Half-Life∅, *BioAv∅, *BBB↑, *toxicity∅, eff↓, Apoptosis↑, Casp3↑, Cyt‑c↑, cl‑PARP↑, DNMTs↓, Telomerase↓, angioG↓, Hif1a↓, NF-kB↓, MMPs↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓, P53↑, PTEN↑, IGF-1↓, H3↓, HDAC1↓, *LDH↓, *ROS↓,
*AntiAge↑, *Dose↑, *BioAv↑, *BioAv↑, *BioAv∅, *BioAv↑, *BioAv↑, *BioAv↑, *BioAv↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, Bak↑, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 1, Cyt‑c↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
PTEN↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
DNMTs↓, 1, H3↓, 1, HDAC1↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, cl‑PARP↑, 1, Telomerase↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
IGF-1↓, 1,
Migration(tgid=13) ⓘ
MMPs↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 1,
Total Targets: 20
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS∅, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 6, BioAv∅, 3, Dose↑, 1, Dose∅, 1, Half-Life∅, 1,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, toxicity∅, 1,
Total Targets: 11
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:792 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page